|
Market Closed -
Nasdaq
16:00:00 2026-08-14 EDT
|
5-day change | 1st Jan Change | ||
| 5.220 USD | +3.78% |
|
+4.40% | -40.82% |
| 08-10 | B. Riley Adjusts Vanda Pharmaceuticals Price Target to $12 From $17, Maintains Buy Rating | MT |
| 08-05 | Vanda Pharmaceuticals Inc., Q2 2026 Earnings Call, Aug 05, 2026 |
| Market Cap | 316M 273M 256M 233M 438M 30.18B 445M 3B 1.17B 15.11B 1.18B 1.16B 50.22B | P/E 2026 * |
-1.73x | P/E 2027 * | -5.07x |
|---|---|---|---|---|---|
| Enterprise Value | 316M 273M 256M 233M 438M 30.18B 445M 3B 1.17B 15.11B 1.18B 1.16B 50.22B | EV / Sales 2026 * |
1.27x | EV / Sales 2027 * | 0.94x |
| Free-Float |
90.83% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Vanda Pharmaceuticals Inc.
| 1 day | +3.78% | ||
| 1 week | +4.40% | ||
| Current month | +2.35% | ||
| 1 month | -10.77% | ||
| 3 months | -16.88% | ||
| 6 months | -14.29% | ||
| Current year | -40.82% |
| 1 week | 4.8 |  | 5.28 |
| 1 month | 4.45 | | 5.53 |
| Current year | 4.45 | | 9.94 |
| 1 year | 4.27 | | 9.94 |
| 3 years | 3.3 | | 9.94 |
| 5 years | 3.3 | | 21.44 |
| 10 years | 3.3 | | 33.44 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 66 | 2003-04-30 | |
Kevin Moran
DFI | Director of Finance/CFO | 42 | 2020-03-14 |
Scott Howell
HRO | Human Resources Officer | 51 | 2019-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 66 | 2021-05-31 | |
Richard Dugan
BRD | Director/Board Member | 84 | 2005-11-30 |
Phaedra Chrousos
BRD | Director/Board Member | 46 | 2019-04-23 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 2/23/26 | Sell | Director | 30,000 | 0.0508% | ||
| 2/18/26 | Free | Chief Executive Officer | 525,000 | 0.8884% | ||
| 2/18/26 | Free | Chief Financial Officer | 125,000 | 0.2115% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.78% | +4.40% | +19.72% | -12.56% | 316M | |
| -1.90% | +2.85% | +62.82% | +104.13% | 70.07B | |
| -3.21% | -4.32% | +31.85% | +57.27% | 52.87B | |
| -2.05% | -5.61% | -3.18% | +449.71% | 27.02B | |
| -1.27% | -1.57% | +45.90% | +8.25% | 23.61B | |
| +1.05% | -0.62% | -18.00% | -11.93% | 23.38B | |
| +3.81% | +20.97% | +266.37% | +531.28% | 19.43B | |
| +0.10% | +1.40% | +35.36% | -19.94% | 18.75B | |
| -0.95% | -3.52% | +19.93% | +594.00% | 15.85B | |
| +1.24% | -5.23% | +33.75% | +137.66% | 12.7B | |
| Average | +0.06% | +2.19% | +49.45% | +183.79% | 26.4B | |
| Weighted average by Cap. | -1.08% | +0.56% | +50.20% | +164.78% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 249M 215M 202M 184M 345M 23.78B 351M 2.36B 925M 11.91B 934M 913M 39.57B | 337M 291M 273M 249M 468M 32.22B 475M 3.2B 1.25B 16.13B 1.26B 1.24B 53.61B |
| Net income | -181M -157M -147M -134M -252M -17.34B -256M -1.72B -674M -8.68B -681M -666M -28.86B | -75.35M -65.08M -61.16M -55.62M -105M -7.21B -106M -717M -280M -3.61B -283M -277M -11.99B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-14 | US$5.220 | +3.78% | 965,067 |
| 26-08-13 | US$5.030 | -3.08% | 864,990 |
| 26-08-12 | US$5.190 | +5.27% | 1,076,326 |
| 26-08-11 | US$4.930 | -1.79% | 1,065,492 |
| 26-08-10 | US$5.020 | +0.40% | 2,000,706 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- VNDA Stock
Select your edition
All financial news and data tailored to specific country editions
